# US 2016/0355786 A1 · Induction of Hemogenic Endothelium from Pluripotent Stem Cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355786 A1
- Document ID: US20160355786A1
- Status: Published application
- Kind: A1
- Application number: 15/183,191
- Filed: 2016-06-15
- Published: 2016-12-08
- Earliest claimed: 2012-10-22
- Assignees: Wisconsin Alumni Research Foundation
- Applicants: Wisconsin Alumni Research Foundation
- Inventors: Igor Slukvin; Irina Elcheva
- Web page: https://patentgrep.com/patent/US20160355786A1

## CPC

- C12N 5/0606: {Pluripotent embryonic cells, e.g. embryonic stem cells [ES] (embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696)}
- C12N 5/0608: {Germ cells (production of embryos, nuclear transfer A01K67/027)}
- C12N 5/0647: {Haematopoietic stem cells; Uncommitted or multipotent progenitors}
- C12N 15/00: Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00)
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/66: General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- C12N 2501/60: Transcription factors
- C12N 2501/998: Proteins not provided for elsewhere
- C12N 2506/02: from embryonic cells
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N 2510/00: Genetically modified cells
- C12N 2740/16043: viral genome or elements thereof as genetic vector
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Described herein are methods and related compositions for inducing differentiation of human pluripotent stem cells (hPSCs) into hemogenic endothelium with pan-myeloid potential or restricted potential, by forced expression in the hPSCs of a combination of transcription factors as described herein.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A kit for hemogenic reprogramming, comprising:
(i) one or more isolated nucleic acids comprising an open reading frame for ETV2 or ERG, and GATA1; or
(ii) one or more recombinant expression viruses suitable for expression, in human pluripotent stem cells, of ETV2 or ERG, and GATA1.

### Claim 22 (depends on 0)

The kit of claim 0, wherein the one or more isolated nucleic acids are modified mRNAs.
